Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

Clinical trial NCT04560881 · COMPLETED

Trial details

NCT number: NCT04560881
Sponsor: Laboratorio Elea Phoenix S.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Virus Infection

Start date: 2020-09-16
Primary completion: 2021-12-13
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.